PharmaDrug Anticipates Biosynthetic Cocaine Commercial-Scale Production In As Little As 12 Months
PharmaDrug Inc (CSE: PHRX) has established a strategic plan to push forward with its intent to support safe supply programs through the use of its patent pending novel manufacturing method for the commercial-scale production of biosynthetic cocaine.
Read more